BeOne Medicines (BEIGF) Net Income - Minority (2017 - 2020)

BeOne Medicines (BEIGF) has 4 years of Net Income - Minority data on file, last reported at -$9.1 million in Q3 2020.

• Net Income - Minority for Q3 2020 came in at -$9.1 million, up 42.15% year-over-year; the trailing twelve-month figure through Sep 2020 was -$9.1 million (up 42.15% YoY), and the FY2019 annual result was -$16.2 million, down 11.8% from the prior year.
• Net Income - Minority rose to -$9.1 million in Q3 2020 per BEIGF's latest filing, from -$10.2 million in the prior quarter.
• Over five years, Net Income - Minority peaked at -$9.1 million in Q3 2020 and troughed at -$17.4 million in Q2 2019.
• A 4-year average of -$13.9 million and a median of -$14.4 million in 2017 frame the typical range for Net Income - Minority.
• The sharpest annual moves came in 2019 and 2020: Net Income - Minority slipped 21.36% in 2019, then soared 42.15% in 2020.
• A 4-year view of Net Income - Minority shows it stood at -$14.4 million in 2017, then decreased by 0.16% to -$14.4 million in 2018, then retreated by 11.8% to -$16.2 million in 2019, then soared by 43.55% to -$9.1 million in 2020.
• Business Quant data shows BEIGF's Net Income - Minority at -$9.1 million in Q3 2020, -$10.2 million in Q2 2020, and -$14.8 million in Q1 2020.